Thomas Illmer, Markus Schaich, Gerhard Ehninger and Christian Thiede (2007) “Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemias”, Haematologica. Pavia, Italy, 92(1), pp. 137-138. doi: 10.3324/haematol.10489.